PMID- 29859319 OWN - NLM STAT- MEDLINE DCOM- 20190906 LR - 20240328 IS - 1095-953X (Electronic) IS - 0969-9961 (Print) IS - 0969-9961 (Linking) VI - 117 DP - 2018 Sep TI - Cocaine-mediated activation of microglia and microglial MeCP2 and BDNF production. PG - 28-41 LID - S0969-9961(18)30155-4 [pii] LID - 10.1016/j.nbd.2018.05.017 [doi] AB - The molecular substrates underlying cocaine reinforcement and addiction have been studied for decades, with a primary focus on signaling molecules involved in modulation of neuronal communication. Brain-derived neurotrophic factor (BDNF) is an important signaling molecule involved in neuronal dendrite and spine modulation. Methyl CpG binding protein 2 (MeCP2) binds to the promoter region of BDNF to negatively regulate its expression and cocaine can recruit MeCP2 to alter the expression of genes such as BDNF that are involved in synaptic plasticity. For several decades, BDNF has been implicated in mediating synaptic plasticity associated with cocaine abuse, and most studies report that neurons are the primary source for BDNF production in the brain. The current study assessed the effects of intravenous cocaine self-administration on microglial activation, and MeCP2 and BDNF expression in reward regions of the brain in vivo, as well as determined specific effects of cocaine exposure on MeCP2 and BDNF expression in human primary neurons and microglia. The results from this study highlight a distinct molecular pathway in microglia through which cocaine increases BDNF, including the phosphorylation of MeCP2 its subsequent translocation from the nucleus to the cytosol, which frees the BDNF promoter and permits its transcriptional activation. Results from these studies show for the first time that cocaine self-administration increases microglial activation, and that microglial MeCP2 is a sensitive target of cocaine resulting in increased release of BDNF from microglia, and possibly contributing to cocaine-induced synaptic plasticity. CI - Copyright (c) 2018 Elsevier Inc. All rights reserved. FAU - Cotto, Bianca AU - Cotto B AD - Department of Neuroscience, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA. FAU - Li, Hongbo AU - Li H AD - Department of Pharmacology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA. FAU - Tuma, Ronald F AU - Tuma RF AD - Department of Pharmacology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA. FAU - Ward, Sara Jane AU - Ward SJ AD - Department of Pharmacology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA. FAU - Langford, Dianne AU - Langford D AD - Department of Neuroscience, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140, USA. Electronic address: tdl@temple.edu. LA - eng GR - P01 DA037830/DA/NIDA NIH HHS/United States GR - P30 DA013429/DA/NIDA NIH HHS/United States GR - P30 MH092177/MH/NIMH NIH HHS/United States GR - R25 MH080661/MH/NIMH NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20180530 PL - United States TA - Neurobiol Dis JT - Neurobiology of disease JID - 9500169 RN - 0 (Bdnf protein, rat) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Dopamine Uptake Inhibitors) RN - 0 (Mecp2 protein, rat) RN - 0 (Methyl-CpG-Binding Protein 2) RN - I5Y540LHVR (Cocaine) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/agonists/*biosynthesis MH - Cells, Cultured MH - Cocaine/*administration & dosage MH - Dopamine Uptake Inhibitors/*administration & dosage MH - Humans MH - Male MH - Methyl-CpG-Binding Protein 2/agonists/*biosynthesis MH - Microglia/*drug effects/*metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Self Administration PMC - PMC6051925 MID - NIHMS972855 OTO - NOTNLM OT - Cocaine OT - Microglia OT - Neuron EDAT- 2018/06/03 06:00 MHDA- 2019/09/07 06:00 PMCR- 2019/09/01 CRDT- 2018/06/03 06:00 PHST- 2017/11/14 00:00 [received] PHST- 2018/05/09 00:00 [revised] PHST- 2018/05/29 00:00 [accepted] PHST- 2018/06/03 06:00 [pubmed] PHST- 2019/09/07 06:00 [medline] PHST- 2018/06/03 06:00 [entrez] PHST- 2019/09/01 00:00 [pmc-release] AID - S0969-9961(18)30155-4 [pii] AID - 10.1016/j.nbd.2018.05.017 [doi] PST - ppublish SO - Neurobiol Dis. 2018 Sep;117:28-41. doi: 10.1016/j.nbd.2018.05.017. Epub 2018 May 30.